Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

Autosomal dominant polycystic kidney disease: updated perspectives.

Rastogi A, Ameen KM, Al-Baghdadi M, Shaffer K, Nobakht N, Kamgar M, Lerma EV.

Ther Clin Risk Manag. 2019 Aug 26;15:1041-1052. doi: 10.2147/TCRM.S196244. eCollection 2019. Review.

2.

Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE.

Roger SD, Spinowitz BS, Lerma EV, Singh B, Packham DK, Al-Shurbaji A, Kosiborod M.

Am J Nephrol. 2019 Oct 28:1-8. doi: 10.1159/000504078. [Epub ahead of print]

3.

Cardiac Troponin T and Right Ventricular Systolic Pressure Predict Cardiovascular and Mortality Risk in Kidney Transplant Candidates.

Firth C, Kaur T, Chakkera H, Zhang N, Shamoun F, Steidley E, Heilman R, Keddis M, Lerma E.

Am J Nephrol. 2019 Oct 22:1-10. doi: 10.1159/000503807. [Epub ahead of print]

PMID:
31639809
4.

Update and review of adult polycystic kidney disease.

Colbert GB, Elrggal ME, Gaur L, Lerma EV.

Dis Mon. 2019 Sep 30:100887. doi: 10.1016/j.disamonth.2019.100887. [Epub ahead of print]

PMID:
31582186
5.

Kidney transplantation for the primary care provider.

Ramaswamy K, Madariaga HM, Thomas BS, Lerma EV.

Dis Mon. 2019 Aug 13:100869. doi: 10.1016/j.disamonth.2019.07.002. [Epub ahead of print]

PMID:
31420084
6.

Class effects of SGLT2 inhibitors on cardiorenal outcomes.

Kluger AY, Tecson KM, Lee AY, Lerma EV, Rangaswami J, Lepor NE, Cobble ME, McCullough PA.

Cardiovasc Diabetol. 2019 Aug 5;18(1):99. doi: 10.1186/s12933-019-0903-4. Review.

7.

Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness.

Revilla G, Pons MP, Baila-Rueda L, García-León A, Santos D, Cenarro A, Magalhaes M, Blanco RM, Moral A, Ignacio Pérez J, Sabé G, González C, Fuste V, Lerma E, Faria MDS, de Leiva A, Corcoy R, Carles Escolà-Gil J, Mato E.

Sci Rep. 2019 Jul 16;9(1):10260. doi: 10.1038/s41598-019-46727-2.

8.

Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study.

Spinowitz BS, Fishbane S, Pergola PE, Roger SD, Lerma EV, Butler J, von Haehling S, Adler SH, Zhao J, Singh B, Lavin PT, McCullough PA, Kosiborod M, Packham DK; ZS-005 Study Investigators.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):798-809. doi: 10.2215/CJN.12651018. Epub 2019 May 20.

PMID:
31110051
9.

Inhibition of the Sodium-Proton Antiporter (Exchanger) is a Plausible Mechanism of Potential Benefit and Harm for Drugs Designed to Block Sodium Glucose Co-transporter 2.

McCullough PA, Kluger AY, Tecson KM, Barbin CM, Lee AY, Lerma EV, Rosol ZP, Kluger SL, Rangaswami J.

Rev Cardiovasc Med. 2018 Jun 30;19(2):51-63. doi: 10.31083/j.rcm.2018.02.021.

10.

Cardiorenal Outcomes in the CANVAS, DECLARE-TIMI 58, and EMPA-REG OUTCOME Trials: A Systematic Review.

Kluger AY, Tecson KM, Barbin CM, Lee AY, Lerma EV, Rosol ZP, Rangaswami J, Lepor NE, Cobble ME, McCullough PA.

Rev Cardiovasc Med. 2018 Jun 30;19(2):41-49. doi: 10.31083/j.rcm.2018.02.907.

11.

Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies.

Rangaswami J, Mathew RO, Parasuraman R, Tantisattamo E, Lubetzky M, Rao S, Yaqub MS, Birdwell KA, Bennett W, Dalal P, Kapoor R, Lerma EV, Lerman M, McCormick N, Bangalore S, McCullough PA, Dadhania DM.

Nephrol Dial Transplant. 2019 May 1;34(5):760-773. doi: 10.1093/ndt/gfz053.

PMID:
30984976
12.

Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association.

Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, Lerma EV, Mezue K, Molitch M, Mullens W, Ronco C, Tang WHW, McCullough PA; American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology.

Circulation. 2019 Apr 16;139(16):e840-e878. doi: 10.1161/CIR.0000000000000664.

PMID:
30852913
13.

Human ApoA-I Overexpression Enhances Macrophage-Specific Reverse Cholesterol Transport but Fails to Prevent Inherited Diabesity in Mice.

Méndez-Lara KA, Farré N, Santos D, Rivas-Urbina A, Metso J, Sánchez-Quesada JL, Llorente-Cortes V, Errico TL, Lerma E, Jauhiainen M, Martín-Campos JM, Alonso N, Escolà-Gil JC, Blanco-Vaca F, Julve J.

Int J Mol Sci. 2019 Feb 2;20(3). pii: E655. doi: 10.3390/ijms20030655.

14.

Fluid distribution timetable on adherence to fluid restriction of patients with end-stage renal disease undergoing haemodialysis: Single-blind, Randomized-Controlled Pilot Study.

Mina RJL, Lerma MB, Litan PLB, Milano AAL, Mojica ADR, Malong-Consolacion CP, Lerma EB, Macindo JRB, Torres GCS.

J Adv Nurs. 2019 Jun;75(6):1328-1337. doi: 10.1111/jan.13964. Epub 2019 Mar 18.

PMID:
30706521
15.

Abdominal compartment syndrome.

Sosa G, Gandham N, Landeras V, Calimag AP, Lerma E.

Dis Mon. 2019 Jan;65(1):5-19. doi: 10.1016/j.disamonth.2018.04.003. Epub 2018 Nov 17. Review. No abstract available.

PMID:
30454823
16.

Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice.

Méndez-Lara KA, Santos D, Farré N, Ruiz-Nogales S, Leánez S, Sánchez-Quesada JL, Zapico E, Lerma E, Escolà-Gil JC, Blanco-Vaca F, Martín-Campos JM, Julve J, Pol O.

PLoS One. 2018 Oct 4;13(10):e0204841. doi: 10.1371/journal.pone.0204841. eCollection 2018.

17.

Practice patterns in transitioning patients from chronic kidney disease to dialysis: a survey of United States nephrologists.

Mallappallil MC, Fishbane S, Wanchoo R, Lerma E, Roche-Recinos A, Salifu M.

BMC Nephrol. 2018 Jun 22;19(1):147. doi: 10.1186/s12882-018-0943-0.

18.

Identification of new biophysical markers for pathological ventricular remodelling in tachycardia-induced dilated cardiomyopathy.

Benitez-Amaro A, Samouillan V, Jorge E, Dandurand J, Nasarre L, de Gonzalo-Calvo D, Bornachea O, Amoros-Figueras G, Lacabanne C, Vilades D, Leta R, Carreras F, Gallardo A, Lerma E, Cinca J, Guerra JM, Llorente-Cortés V.

J Cell Mol Med. 2018 Sep;22(9):4197-4208. doi: 10.1111/jcmm.13699. Epub 2018 Jun 19.

19.

Renal complications during pregnancy: In the hypertension spectrum.

Calimag-Loyola APP, Lerma EV.

Dis Mon. 2019 Feb;65(2):25-44. doi: 10.1016/j.disamonth.2018.03.001. Epub 2018 Jun 8. Review.

PMID:
29891230
20.

Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data.

Zardavas D, Te Marvelde L, Milne RL, Fumagalli D, Fountzilas G, Kotoula V, Razis E, Papaxoinis G, Joensuu H, Moynahan ME, Hennessy BT, Bieche I, Saal LH, Stal O, Iacopetta B, Jensen JD, O'Toole S, Lopez-Knowles E, Barbaraeschi M, Noguchi S, Azim HA Jr, Lerma E, Bachelot T, Wang Q, Perez-Tenorio G, Can de Velde CJH, Rea DW, Sabine V, Bartlett JMS, Sotiriou C, Michiels S, Loi S.

J Clin Oncol. 2018 Apr 1;36(10):981-990. doi: 10.1200/JCO.2017.74.8301. Epub 2018 Feb 22.

21.

Trends in AIDS Mortality, Retention in Opioid Agonist Therapy, and HIV RNA Suppression in HIV-Infected People Who Injected Drugs from 2000 to 2015.

Vallecillo G, Robles MJ, Durán X, Lerma E, Horcajada JP, Torrens M.

AIDS Behav. 2018 Sep;22(9):2766-2772. doi: 10.1007/s10461-018-2033-5.

PMID:
29372455
22.

Frequency and severity of potential drug interactions in a cohort of HIV-infected patients Identified through a Multidisciplinary team.

Molas E, Luque S, Retamero A, Echeverría-Esnal D, Guelar A, Montero M, Guerri R, Sorli L, Lerma E, Villar J, Knobel H.

HIV Clin Trials. 2018 Feb;19(1):1-7. doi: 10.1080/15284336.2017.1404690. Epub 2017 Nov 28.

PMID:
29179644
23.

Response letter to: Questions about Ki67 staining in luminal breast cancer.

Gallardo A, Lerma E.

Breast Cancer Res Treat. 2018 Jan;167(2):601. doi: 10.1007/s10549-017-4524-x. Epub 2017 Sep 27. No abstract available.

PMID:
28956205
24.

Clinical hypertension: Blood pressure variability.

Malik EZ, Abdulhadi B, Mezue KN, Lerma EV, Rangaswami J.

Dis Mon. 2018 Jan;64(1):5-13. doi: 10.1016/j.disamonth.2017.08.003. Epub 2017 Sep 19. Review. No abstract available.

PMID:
28939280
25.

Inverse relationship between Ki67 and survival in early luminal breast cancer: confirmation in a multivariate analysis.

Gallardo A, Garcia-Valdecasas B, Murata P, Teran R, Lopez L, Barnadas A, Lerma E.

Breast Cancer Res Treat. 2018 Jan;167(1):31-37. doi: 10.1007/s10549-017-4486-z. Epub 2017 Sep 1.

PMID:
28865009
26.

Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial.

Villar-García J, Güerri-Fernández R, Moya A, González A, Hernández JJ, Lerma E, Guelar A, Sorli L, Horcajada JP, Artacho A, D Auria G, Knobel H.

PLoS One. 2017 Apr 7;12(4):e0173802. doi: 10.1371/journal.pone.0173802. eCollection 2017.

27.

Nephroendocrinology: When endocrinology meets nephrology.

Lerma EV, Koch CA.

Rev Endocr Metab Disord. 2017 Mar;18(1):1-3. doi: 10.1007/s11154-017-9419-y. No abstract available.

PMID:
28337588
28.

Cardio-Renal Syndrome: A double edged sword.

Naranjo M, Lerma EV, Rangaswami J.

Dis Mon. 2017 Apr;63(4):92-100. doi: 10.1016/j.disamonth.2017.02.001. Epub 2017 Mar 14. No abstract available.

PMID:
28302277
29.

Effects of staged versus ad hoc percutaneous coronary interventions on renal function-Is there a benefit to staging?

Shah M, Gajanana D, Wheeler DS, Punjabi C, Maludum O, Mezue K, Lerma EV, Ardati A, Romero-Corral A, Witzke C, Rangaswami J.

Cardiovasc Revasc Med. 2017 Jul - Aug;18(5):344-348. doi: 10.1016/j.carrev.2017.02.017. Epub 2017 Feb 28.

PMID:
28285786
30.

The Evolution of the Journal Club: From Osler to Twitter.

Topf JM, Sparks MA, Phelan PJ, Shah N, Lerma EV, Graham-Brown MPM, Madariaga H, Iannuzzella F, Rheault MN, Oates T, Jhaveri KD, Hiremath S.

Am J Kidney Dis. 2017 Jun;69(6):827-836. doi: 10.1053/j.ajkd.2016.12.012. Epub 2017 Feb 21. Review.

PMID:
28233653
31.

CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma.

Sanmartín E, Ortiz-Martínez F, Pomares-Navarro E, García-Martínez A, Rodrigo-Baños M, García-Escolano M, Andrés L, Lerma E, Aranda FI, Martínez-Peinado P, Sempere-Ortells JM, Peiró G.

Virchows Arch. 2017 Jan;470(1):81-90. doi: 10.1007/s00428-016-2045-3. Epub 2016 Nov 24.

PMID:
27885422
32.

Hepatorenal syndrome.

Shah N, Silva RG, Kowalski A, Desai C, Lerma E.

Dis Mon. 2016 Oct;62(10):364-375. doi: 10.1016/j.disamonth.2016.05.009. Epub 2016 Jun 29. Review. No abstract available.

PMID:
27372112
33.

ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer.

Cedó L, García-León A, Baila-Rueda L, Santos D, Grijalva V, Martínez-Cignoni MR, Carbó JM, Metso J, López-Vilaró L, Zorzano A, Valledor AF, Cenarro A, Jauhiainen M, Lerma E, Fogelman AM, Reddy ST, Escolà-Gil JC, Blanco-Vaca F.

Sci Rep. 2016 Nov 3;6:36387. doi: 10.1038/srep36387.

34.

Portal hypertension: Etiology, evaluation, and management.

Tetangco EP, Silva RG, Lerma EV.

Dis Mon. 2016 Dec;62(12):411-426. doi: 10.1016/j.disamonth.2016.08.001. Epub 2016 Oct 24. Review. No abstract available.

PMID:
27788916
35.

Quantifying the Twitter Influence of Third Party Commercial Entities versus Healthcare Providers in Thirteen Medical Conferences from 2011 - 2013.

Desai T, Dhingra V, Shariff A, Shariff A, Lerma E, Singla P, Kachare S, Syed Z, Minhas D, Madanick R, Fang X.

PLoS One. 2016 Sep 26;11(9):e0162376. doi: 10.1371/journal.pone.0162376. eCollection 2016.

36.

Two Cases of Acute Renal Infarction in the Setting of Atrial Fibrillation.

Yousuf T, Ziffra J, Iqbal H, Said A, Oyama JH, Lerma EV, Chadaga AR.

Ochsner J. 2016 Fall;16(3):312-4.

37.

Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ Tregs.

Ortiz-Martínez F, Gutiérrez-Aviñó FJ, Sanmartín E, Pomares-Navarro E, Villalba-Riquelme C, García-Martínez A, Lerma E, Peiró G.

Exp Mol Pathol. 2016 Jun;100(3):460-8. doi: 10.1016/j.yexmp.2016.04.006. Epub 2016 Apr 23.

PMID:
27118257
38.

Mineral metabolism in chronic kidney disease.

Kochanek M, Said A, Lerma EV.

Dis Mon. 2015 Oct;61(10):425-33. doi: 10.1016/j.disamonth.2015.08.003. Review. No abstract available.

PMID:
26518114
39.

Twitter-Based Journal Clubs: Additional Facts and Clarifications.

Topf JM, Sparks MA, Iannuzzella F, Lerma E, Oates T, Phelan PJ, Hiremath S.

J Med Internet Res. 2015 Sep 16;17(9):e216. doi: 10.2196/jmir.4639. No abstract available.

40.

Autosomal dominant polycystic kidney disease.

Silverman J, Desai C, Lerma EV.

Dis Mon. 2015 Oct;61(10):442-7. doi: 10.1016/j.disamonth.2015.08.005. Epub 2015 Sep 11. Review. No abstract available.

PMID:
26364947
41.

Anemia of chronic kidney disease.

Kutuby F, Wang S, Desai C, Lerma EV.

Dis Mon. 2015 Oct;61(10):421-4. doi: 10.1016/j.disamonth.2015.08.002. Epub 2015 Sep 11. Review. No abstract available.

PMID:
26364946
42.

Nephrolithiasis for the primary care physician.

Tan JA, Lerma EV.

Dis Mon. 2015 Oct;61(10):434-41. doi: 10.1016/j.disamonth.2015.08.004. Epub 2015 Sep 9. Review. No abstract available.

PMID:
26362879
43.

Chronic kidney disease.

Said A, Desai C, Lerma EV.

Dis Mon. 2015 Sep;61(9):374-7. doi: 10.1016/j.disamonth.2015.08.001. Epub 2015 Sep 2. Review. No abstract available.

PMID:
26342715
44.

Cardiovascular disease and chronic kidney disease.

Gargiulo R, Suhail F, Lerma EV.

Dis Mon. 2015 Sep;61(9):403-13. doi: 10.1016/j.disamonth.2015.07.005. Epub 2015 Aug 29. Review. No abstract available.

PMID:
26328516
45.

Hypertension and chronic kidney disease.

Gargiulo R, Suhail F, Lerma EV.

Dis Mon. 2015 Sep;61(9):387-95. doi: 10.1016/j.disamonth.2015.07.003. Epub 2015 Aug 29. Review. No abstract available.

PMID:
26328515
46.

Diabetes and chronic kidney disease.

Kowalski A, Krikorian A, Lerma EV.

Dis Mon. 2015 Sep;61(9):378-86. doi: 10.1016/j.disamonth.2015.07.002. Epub 2015 Aug 28. Review. No abstract available.

PMID:
26318277
47.

Dyslipidemia in chronic kidney disease.

Kowalski A, Krikorian A, Lerma EV.

Dis Mon. 2015 Sep;61(9):396-402. doi: 10.1016/j.disamonth.2015.07.004. Epub 2015 Aug 24. Review. No abstract available.

PMID:
26315102
48.

Renal LECT2 amyloidosis: a newly described disorder gaining greater recognition.

Kowalski A, Cabrera J, Nasr S, Lerma E.

Clin Nephrol. 2015 Oct;84(4):236-40. doi: 10.5414/CN108549. Review.

PMID:
26308079
49.

FOXA2 mRNA expression is associated with relapse in patients with Triple-Negative/Basal-like breast carcinoma.

Perez-Balaguer A, Ortiz-Martínez F, García-Martínez A, Pomares-Navarro C, Lerma E, Peiró G.

Breast Cancer Res Treat. 2015 Sep;153(2):465-74. doi: 10.1007/s10549-015-3553-6. Epub 2015 Aug 23.

PMID:
26298189
50.

Intratumor cholesteryl ester accumulation is associated with human breast cancer proliferation and aggressive potential: a molecular and clinicopathological study.

de Gonzalo-Calvo D, López-Vilaró L, Nasarre L, Perez-Olabarria M, Vázquez T, Escuin D, Badimon L, Barnadas A, Lerma E, Llorente-Cortés V.

BMC Cancer. 2015 Jun 9;15:460. doi: 10.1186/s12885-015-1469-5.

Supplemental Content

Support Center